SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0696+1.6%Nov 5 3:22 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mammon5/27/2014 10:21:34 AM
2 Recommendations

Recommended By
Jack Russell
Littlebits

  Read Replies (2) of 13111
 
From Alan Ross's interview with Pete Culpepper, posted on Investor Village.

"
10. Have you gotten feedback on the FDA letter from the medical community and/or other pharmaceutical companies (like those represented on your Strategic Advisory Board) and can you share them with us?

Answer: Yes we have, and it is not appropriate to share at this time, other than to say the retail mindset of BTD and consequences of being denied is very much different than that of life science professionals."

that's exactly what I was hoping to hear. :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News